Quick Answer
Axogen, Inc. reported Cash And Cash Equivalents At Carrying Value of $35.55 million for the year ending 2025.
- Axogen, Inc. showed an increase of +29.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Axogen, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Axogen, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 12,470.0%.
- Historical annual values: Fiscal year 2025: $35.55 million | Fiscal year 2024: $27.55 million | Fiscal year 2023: $31.02 million | Fiscal year 2022: $15.28 million | Fiscal year 2021: $32.76 million | Fiscal year 2020: $48.77 million | Fiscal year 2019: $35.72 million | Fiscal year 2018: $24.29 million | Fiscal year 2017: $36.51 million | Fiscal year 2016: $30.01 million | Fiscal year 2015: $25.91 million | Fiscal year 2014: $8.22 million | Fiscal year 2013: $20.07 million | Fiscal year 2012: $13.91 million | Fiscal year 2011: $8.19 million | Fiscal year 2010: $1.80 million | Fiscal year 2009: $282.8 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: